A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Status:
Active, not recruiting
Trial end date:
2024-05-24
Target enrollment:
Participant gender:
Summary
This is a study of tirzepatide in participants with overweight and obesity. The main purpose
is to learn more about how tirzepatide affects body weight. The study has two phases: A main
phase and an extension phase. The main phase of the study will last 72 weeks (14 visits).
Participants with prediabetes will continue in the extension for another 2 years.